FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004497788> ?p ?o ?g. }

• W2004497788 endingPage "1093" @default.
• W2004497788 startingPage "1087" @default.
• W2004497788 abstract "Aim To evaluate the effect of hyoscine butylbromide (HBB) on image quality and lesion and organ visualization in pelvic magnetic resonance imaging (MRI) Materials and methods A prospective, ethically approved study was undertaken of 47 patients attending for pelvic MRI at a cancer centre. T2-weighted transverse and sagittal sequences were performed before and after intravenous injection of 20 mg HBB. Three radiologists independently scored anonymized image series for overall image quality, visualization of pelvic lesions and visualization of individual pelvic organs. Statistical analysis was performed to assess improvements in radiologists' scores post-HBB administration. Radiologists also assessed pre-HBB administration T1-weighted images for degree of bowel peristalsis to determine whether this could predict improvement in post-HBB T2-weighted image scores. Side effects of HBB were recorded using a patient questionnaire. Results Radiologists' scores for image quality and lesion visualization were significantly higher on the post-HBB administration T2-weighted series (p<0.0005). Scores for the visualization of the bladder, rectum, pelvic bowel, prostate, and seminal vesicles (all p<0.0005), cervix (p=0.019) and vagina (p=0.0001) were also significantly higher post-HBB administration. Scores for the degree of peristalsis on T1-weighted images were not related to improvement in image quality or lesion visualization on T2-weighted images post-HBB administration. Side effects of HBB were mild and self-limiting. Conclusion Intravenous HBB administration improves image quality and lesion visualization in oncological pelvic MRI and is recommended for routine use. To evaluate the effect of hyoscine butylbromide (HBB) on image quality and lesion and organ visualization in pelvic magnetic resonance imaging (MRI) A prospective, ethically approved study was undertaken of 47 patients attending for pelvic MRI at a cancer centre. T2-weighted transverse and sagittal sequences were performed before and after intravenous injection of 20 mg HBB. Three radiologists independently scored anonymized image series for overall image quality, visualization of pelvic lesions and visualization of individual pelvic organs. Statistical analysis was performed to assess improvements in radiologists' scores post-HBB administration. Radiologists also assessed pre-HBB administration T1-weighted images for degree of bowel peristalsis to determine whether this could predict improvement in post-HBB T2-weighted image scores. Side effects of HBB were recorded using a patient questionnaire. Radiologists' scores for image quality and lesion visualization were significantly higher on the post-HBB administration T2-weighted series (p<0.0005). Scores for the visualization of the bladder, rectum, pelvic bowel, prostate, and seminal vesicles (all p<0.0005), cervix (p=0.019) and vagina (p=0.0001) were also significantly higher post-HBB administration. Scores for the degree of peristalsis on T1-weighted images were not related to improvement in image quality or lesion visualization on T2-weighted images post-HBB administration. Side effects of HBB were mild and self-limiting. Intravenous HBB administration improves image quality and lesion visualization in oncological pelvic MRI and is recommended for routine use." @default.
• W2004497788 created "2016-06-24" @default.
• W2004497788 creator A5025297977 @default.
• W2004497788 creator A5029123237 @default.
• W2004497788 creator A5031345119 @default.
• W2004497788 creator A5064045418 @default.
• W2004497788 creator A5075533496 @default.
• W2004497788 date "2007-11-01" @default.
• W2004497788 modified "2023-10-10" @default.
• W2004497788 title "The value of hyoscine butylbromide in pelvic MRI" @default.
• W2004497788 cites W1999930209 @default.
• W2004497788 cites W2037385180 @default.
• W2004497788 cites W2048236746 @default.
• W2004497788 cites W2052524972 @default.
• W2004497788 cites W216229506 @default.
• W2004497788 cites W2411833988 @default.
• W2004497788 doi "https://doi.org/10.1016/j.crad.2007.05.007" @default.
• W2004497788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17920868" @default.
• W2004497788 hasPublicationYear "2007" @default.
• W2004497788 type Work @default.
• W2004497788 sameAs 2004497788 @default.
• W2004497788 citedByCount "70" @default.
• W2004497788 countsByYear W20044977882012 @default.
• W2004497788 countsByYear W20044977882013 @default.
• W2004497788 countsByYear W20044977882014 @default.
• W2004497788 countsByYear W20044977882015 @default.
• W2004497788 countsByYear W20044977882016 @default.
• W2004497788 countsByYear W20044977882017 @default.
• W2004497788 countsByYear W20044977882018 @default.
• W2004497788 countsByYear W20044977882019 @default.
• W2004497788 countsByYear W20044977882020 @default.
• W2004497788 countsByYear W20044977882021 @default.
• W2004497788 countsByYear W20044977882022 @default.
• W2004497788 countsByYear W20044977882023 @default.
• W2004497788 crossrefType "journal-article" @default.
• W2004497788 hasAuthorship W2004497788A5025297977 @default.
• W2004497788 hasAuthorship W2004497788A5029123237 @default.
• W2004497788 hasAuthorship W2004497788A5031345119 @default.
• W2004497788 hasAuthorship W2004497788A5064045418 @default.
• W2004497788 hasAuthorship W2004497788A5075533496 @default.
• W2004497788 hasConcept C126322002 @default.
• W2004497788 hasConcept C126838900 @default.
• W2004497788 hasConcept C142724271 @default.
• W2004497788 hasConcept C143409427 @default.
• W2004497788 hasConcept C154945302 @default.
• W2004497788 hasConcept C178910020 @default.
• W2004497788 hasConcept C2781074409 @default.
• W2004497788 hasConcept C2781156865 @default.
• W2004497788 hasConcept C2989005 @default.
• W2004497788 hasConcept C36464697 @default.
• W2004497788 hasConcept C41008148 @default.
• W2004497788 hasConcept C71924100 @default.
• W2004497788 hasConceptScore W2004497788C126322002 @default.
• W2004497788 hasConceptScore W2004497788C126838900 @default.
• W2004497788 hasConceptScore W2004497788C142724271 @default.
• W2004497788 hasConceptScore W2004497788C143409427 @default.
• W2004497788 hasConceptScore W2004497788C154945302 @default.
• W2004497788 hasConceptScore W2004497788C178910020 @default.
• W2004497788 hasConceptScore W2004497788C2781074409 @default.
• W2004497788 hasConceptScore W2004497788C2781156865 @default.
• W2004497788 hasConceptScore W2004497788C2989005 @default.
• W2004497788 hasConceptScore W2004497788C36464697 @default.
• W2004497788 hasConceptScore W2004497788C41008148 @default.
• W2004497788 hasConceptScore W2004497788C71924100 @default.
• W2004497788 hasIssue "11" @default.
• W2004497788 hasLocation W20044977881 @default.
• W2004497788 hasLocation W20044977882 @default.
• W2004497788 hasOpenAccess W2004497788 @default.
• W2004497788 hasPrimaryLocation W20044977881 @default.
• W2004497788 hasRelatedWork W196651854 @default.
• W2004497788 hasRelatedWork W2002721943 @default.
• W2004497788 hasRelatedWork W2007490384 @default.
• W2004497788 hasRelatedWork W2041959407 @default.
• W2004497788 hasRelatedWork W2069533287 @default.
• W2004497788 hasRelatedWork W2157260450 @default.
• W2004497788 hasRelatedWork W2373369013 @default.
• W2004497788 hasRelatedWork W2378398428 @default.
• W2004497788 hasRelatedWork W2986779194 @default.
• W2004497788 hasRelatedWork W2993882870 @default.
• W2004497788 hasVolume "62" @default.
• W2004497788 isParatext "false" @default.
• W2004497788 isRetracted "false" @default.
• W2004497788 magId "2004497788" @default.
• W2004497788 workType "article" @default.